Last update: May 1, 2019
Increased level of risk
New scientific evidences have driven the Apilam staff to update the level of risk associated to this product.
Former level of risk, which was Low Risk probable, is now set to High Risk probable.
Level of risk reviewed on April 8, 2019
Poorly safe. Evaluate carefully.
Use safer alternative or interrupt breastfeeding several T½.
Read the Comment.
Multiralgim is a tradename that contains a main active ingredient in its composition:
For more information (pharmacokinetics, references, ...) tap the name of the active ingredient.
It is not intended to replace the relationship you have with your doctor but to compound it.
Thank you for helping to protect and promote breastfeeding.